Cargando…
Targeted genetic and epigenetic profiling of esophageal adenocarcinomas and non-dysplastic Barrett’s esophagus
BACKGROUND: Despite the efforts to describe the molecular landscape of esophageal adenocarcinoma (EAC) and its precursor lesion Barrett’s esophagus (BE), discrepant findings are reported. Here, we investigated the prevalence of selected genetic (TP53 mutations and microsatellite instability (MSI) st...
Autores principales: | Pinto, Rita, Hauge, Tobias, Jeanmougin, Marine, Pharo, Heidi D., Kresse, Stine H., Honne, Hilde, Winge, Sara B., Five, May-Britt, Kumar, Theresa, Mala, Tom, Hauge, Truls, Johnson, Egil, Lind, Guro E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9195284/ https://www.ncbi.nlm.nih.gov/pubmed/35701814 http://dx.doi.org/10.1186/s13148-022-01287-7 |
Ejemplares similares
-
Evaluation of commercial kits for isolation and bisulfite conversion of circulating cell-free tumor DNA from blood
por: Kresse, Stine H., et al.
Publicado: (2023) -
BladMetrix: a novel urine DNA methylation test with high accuracy for detection of bladder cancer in hematuria patients
por: Pharo, Heidi Dietrichson, et al.
Publicado: (2022) -
Experimental factors affecting the robustness of DNA methylation analysis
por: Pharo, Heidi D., et al.
Publicado: (2016) -
The role of ablation in the treatment of dysplastic Barrett’s esophagus
por: Sullivan, Rebecca, et al.
Publicado: (2021) -
State-of-the-art management of dysplastic Barrett's esophagus
por: Vantanasiri, Kornpong, et al.
Publicado: (2022)